GlassScriptPhysician profile
Andrew Meyer Shum
NPI 1528414547
$1,886.59
in general payments reported to CMS, 2019-2025
17 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $108 · 2021: $194 · 2022: $190 · 2023: $495 · 2024: $267 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $365.23 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $317.08 | 2022-2025 | Infuse |
| Alcon Vision LLC | $281.64 | 2019-2025 | Total30 |
| Johnson & Johnson Surgical Vision, INC. | $137.27 | 2019-2023 | Lipiflow System Activator (Disposable) |
| Coopervision INC. | $127.10 | 2019-2023 | Myday Contact Lens, Misight Contact Lens |
| Dompe US, INC. | $124.92 | 2024 | Oxervate |
| Glaukos Corporation | $110.29 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.76 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $99.27 | 2019 | |
| Sun Pharmaceutical Industries INC. | $54.35 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $44.76 | 2020-2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $36.77 | 2021-2022 | |
| Astellas Pharma US INC | $27.05 | 2024 | Izervay |
| Allergan, INC. | $20.36 | 2021 | |
| Kala Pharmaceuticals, INC. | $16.78 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synergeyes, INC. | $12.22 | 2019 | |
| Optos, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Shum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.